Molecular Cytogenetics Market Growth Outlook Through 2024-2033

Overview and Scope
Molecular cytogenetics refers to a set of techniques that operate with the entire genome or with specific targeted DNA sequences. It includes the structural and functional organization of the chromosome and nucleus, genome variation, expression, evolution, chromosome abnormalities, and genomic variations in the context of medical genetics and tumor genetics.

Sizing and Forecast
The molecular cytogenetics market size has grown rapidly in recent years. It will grow from $2.65 billion in 2023 to $2.93 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rise in genetic disorders and cancer cases, growing demand for personalized medicine, research and development in life sciences, clinical applications for prenatal and postnatal diagnosis, global initiatives in genomic medicine.

The molecular cytogenetics market size is expected to see strong growth in the next few years. It will grow to $4.24 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emergence of next-generation sequencing (ngs), increased focus on liquid biopsies, growing application in cancer research, expanding applications in infectious disease diagnosis, rapid growth in genetic testing services. Major trends in the forecast period include next-generation sequencing (ngs) in cytogenetic, automation and high-throughput screening, fluorescence in situ hybridization (fish) advancements, rising application in cancer diagnostics, single-cell analysis.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/molecular-cytogenetics-global-market-report

Segmentation & Regional Insights
The molecular cytogenetics market covered in this report is segmented –

1) By Product: Instruments, Kits And Reagents, Software, Services, Consumables Or Accessories
2) By Technology: Comparative Genomic Hybridization, Fluorescence In Situ Hybridization, Immunohistochemistry, Karyotyping, Other Technologies
3) By Application: Genetic Disorders, Cancer, Personalized Medicines, Other Applications
4) By End-User: Clinical And Research Laboratories, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Other End-Users

North America was the largest region in the molecular cytogenetics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global molecular cytogenetics market report during the forecast period. The regions covered in the molecular cytogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10096&type=smp

Major Driver Impacting Market Growth
The increasing incidence of genetic disorders and cancer is expected to drive the growth of the molecular cytogenetics market going forward. Cancer refers to a disease in which the body’s cells grow uncontrollably and spread to other parts of the body. Cytogenetics testing samples of tissue and blood are used for changes in chromosomes, such as broken, missing, or rearranged chromosomes. Changes in certain chromosomes are a sign of a genetic disease, condition, or some types of cancer. Hence, the increasing incidence of genetic disorders and cancer will propel the growth of the market. For instance, according to the American Cancer Society, a US-based nationwide voluntary health organization, by 2040, the global burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths. Additionally, in 2022, 1,918,030 new cancer cases and 609,360 cancer deaths occurred in the United States, including approximately 350 deaths per day from lung cancer. Therefore, the increasing incidence of genetic disorders and cancer is driving the growth of the molecular cytogenetics market.

Key Industry Players

Major companies operating in the molecular cytogenetics market report are Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging, CytoTest Inc., Danaher Corporation, Illumina Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Oxford Gene Technology Limited, Affymetrix Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, F. Hoffmann-La Roche AG, Bi Biological industries, Cytognomix Inc., Empire Genomics LLC., Genial Genetic Solutions Ltd., BioChain Institute Inc., BioGenex Laboratories Inc., Bio-Techne Corporation, Cytocell Ltd., Kreatech Diagnostics B.V., Leica Biosystems Nussloch GmbH, MetaSystems Group Holding GmbH, MolecularMD Corporation, Natera Inc., Opko Health Inc., PathGroup Inc., Roche Diagnostics Corporation, SciGene Corporation, SkylineDx B.V.

The molecular cytogenetics market report table of contents includes:

1. Executive Summary
2. Molecular Cytogenetics Market Characteristics
3. Molecular Cytogenetics Market Trends And Strategies
4. Molecular Cytogenetics Market – Macro Economic Scenario
5. Global Molecular Cytogenetics Market Size and Growth
.
.
.
31. Global Molecular Cytogenetics Market Competitive Benchmarking
32. Global Molecular Cytogenetics Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Molecular Cytogenetics Market
34. Molecular Cytogenetics Market Future Outlook and Potential Analysis
35. Appendix

Explore the trending research reports from TBRC:

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model